Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study
tildrakizumab治疗活动性银屑病关节炎患者的疗效和安全性:一项随机、双盲、安慰剂对照、多剂量、为期52周的IIb期研究结果
期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/annrheumdis-2020-219014
Mease, Philip J; Chohan, Saima; Fructuoso, Ferran J Garcia; Luggen, Michael E; Rahman, Proton; Raychaudhuri, Siba P; Chou, Richard C; Mendelsohn, Alan M; Rozzo, Stephen J; Gottlieb, Alice